SIRFLOX_3: SIRFLOX, figure 3

SIRFLOX_3R Documentation

SIRFLOX, figure 3

Description

Kaplan-Meier digitized data from SIRFLOX, figure 3 (PMID 26903575). A reported sample size of 530 for a primary endpoint of PFS in colorectal cancer.

Usage

SIRFLOX_3

Format

A data frame of 530 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (mfolfox6, mfolfox6_rt)

Source

van Hazel GA, Heinemann V, Sharma NK, et al. SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. J Clin Oncol 2016; 34: 1723–31.

Examples

summary(SIRFLOX_3)

kmplot(SIRFLOX_3)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.